Ken Griffin
ROIV icon

Ken Griffin’s Roivant Sciences ROIV Stock Holding History

Ken Griffin’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.7M Buy
2,515,998
+229,997
+10% +$5.91M 0.01% 1089
2025
Q4 		$49.6M Buy
2,286,001
+1,317,798
+136% +$26M 0.01% 1421
2025
Q3 		$14.6M Buy
968,203
+476,071
+97% +$5.89M ﹤0.01% 2725
2025
Q2 		$5.55M Sell
492,132
-859,209
-64% -$9.31M ﹤0.01% 3923
2025
Q1 		$13.6M Sell
1,351,341
-453,438
-25% -$4.9M ﹤0.01% 2479
2024
Q4 		$21.4M Sell
1,804,779
-4,123,404
-70% -$48.8M ﹤0.01% 2095
2024
Q3 		$68.4M Buy
5,928,183
+4,004,146
+208% +$45.6M 0.01% 965
2024
Q2 		$20.3M Sell
1,924,037
-1,215,542
-39% -$13.3M ﹤0.01% 1984
2024
Q1 		$33.1M Sell
3,139,579
-342,124
-10% -$3.69M 0.01% 1566
2023
Q4 		$39.1M Buy
3,481,703
+3,355,500
+2,659% +$32.7M 0.01% 1370
2023
Q3 		$1.47M Buy
126,203
+101,024
+401% +$1.14M ﹤0.01% 5805
2023
Q2 		$254K Sell
25,179
-1,378,661
-98% -$12.3M ﹤0.01% 9378
2023
Q1 		$10.4M Buy
1,403,840
+539,869
+62% +$4.45M ﹤0.01% 2780
2022
Q4 		$6.9M Sell
863,971
-570,054
-40% -$3.17M ﹤0.01% 3349
2022
Q3 		$4.62M Buy
1,434,025
+1,246,676
+665% +$4.83M ﹤0.01% 4005
2022
Q2 		$762K Buy
+187,349
New +$744K ﹤0.01% 7653

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ken Griffin's ROIV Position: Q1 2026 in Review

Ken Griffin increased its Roivant Sciences (ROIV) stake by 10% in Q1 2026, buying an estimated $5.91M and bringing the position to 2,515,998 shares worth $69.7M. The position accounts for 0.01% of the portfolio, ranked #1089.

Ken Griffin first reported a position in ROIV in Q2 2022 and has held it in 16 quarters since. 442 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Ken Griffin held 2,515,998 shares of Roivant Sciences worth $69.7M as of Q1 2026.
  • Ken Griffin bought 229,997 Roivant Sciences shares in Q1 2026, an estimated $5.91M.
  • Roivant Sciences made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #1089 holding.
  • Ken Griffin first reported a position in Roivant Sciences in Q2 2022 and has held it in 16 quarters since.
  • 442 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.